<DOC>
	<DOCNO>NCT01526343</DOCNO>
	<brief_summary>While surgical treatment atrial fibrillation ( AF ) perform 20 year , virtually historical series report recurrence symptomatic AF use intermittent electrocardiogram ( ECG ) follow-up . This study compare use traditional arrhythmia assessment ( ECG 24-hour holter monitoring ) use Medtronic Reveal XT device continuously record heart rhythm quantify postoperative arrhythmia burden follow surgical treatment AF patient undergo either lone concomitant heart surgery .</brief_summary>
	<brief_title>Medtronic Reveal XT Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patients undergo plan , elective AF surgery , either standalone procedure concomitant cardiac operation . 2 . Patients either CoxMaze procedure ( fullbiatrial lesion set ) surgical pulmonary vein isolation ( PVI ) . 3 . Patients 18 year old . 4 . All eligible patient consider , regardless gender race . 5 . Patients able willing provide inform consent willing comply require interval followup . 1 . Patients preoperative permanent pacemaker . 2 . Patients project lifespan less six month . 3 . Patients require emergent cardiac surgery . 4 . Patients unwilling unable give write informed consent . 5 . Patients undergo right atrial leave atrial lesion set procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Patients</keyword>
</DOC>